Healthcare providers are facing unprecedented challenges, including aging populations and an increase in cardiovascular diseases. Innovative solutions are therefore needed to streamline workflows and ease the pressure on imaging services. Visitors to the Fujifilm booth will be able to view its latest technologies to address these challenges, including the LISENDO™ 880 ultrasound system, the ARIETTA™ 650 and 750 DeepInsight™ ultrasound platforms, and the 4D TTE and TEE Matrix transducers. The knowledgeable Fujifilm team will be happy to discuss how these tools can assist in the early detection of heart disease pathologies, including:

• Hemodynamic Analytics to help detect early signs of heart failure;
• Artificial Intelligence to empower cardiac examinations with quick and precise data;
• High power 3D/4D imaging for better visualization of cardiac anatomy, allowing detection of even the smallest anomalies;
• Complete ultrasound imaging solutions to help improve the efficiency and accuracy of diagnoses.

Visit Fujifilm’s EACVI information page to learn more, and see how you can work with the company to take on the challenge together.

™ indicates a trademark of FUJIFILM Corporation or other Fujifilm group company

FUJIFILM Healthcare Europe, headquartered in Ratingen, Germany, is a leading supplier of innovative medical imaging systems that provide comprehensive diagnostic solutions for a wide range of applications. Its complete and integrated portfolio of products and services includes ultrasound, clinical MRI, CT, mammography and healthcare IT platforms, as well as radiology, endoscopy and IVD for human and veterinary use. FUJIFILM Healthcare Europe combines state-of-the-art devices with AI technologies and advanced image processing techniques to help improve patient care. As healthcare settings continue to embrace the integration of diagnostic hardware and predictive analytics, FUJIFILM Healthcare Europe is with them every step of the way, taking on the challenge together.